Non-Small Cell Lung Cancer with HER2 Exon 20 Mutation: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment

Eitemau Tebyg

• HER2-Amplified Salivary Duct Carcinoma: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment
  gan: Falchook, Gerald S., et al.
  Cyhoeddwyd: (2013)
• VEGF and dual-EGFR inhibition in colorectal cancer
  gan: Falchook, Gerald S, et al.
  Cyhoeddwyd: (2015)
• Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancer
  gan: Falchook, Gerald S., et al.
  Cyhoeddwyd: (2014)
• Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer(†)
  gan: Falchook, G. S., et al.
  Cyhoeddwyd: (2013)
• Dual EGFR inhibition in combination with anti-VEGF treatment: A phase I clinical trial in non-small cell lung cancer
  gan: Falchook, Gerald S., et al.
  Cyhoeddwyd: (2013)